Histamine is an important neurotransmitter that contributes to various processes, including the sleepwake cycle, learning, memory, and stress responses. its actions are mediated through histamine H 1 -H 4 receptors. Gene knockout and pharmacological studies have revealed the importance of H 1 receptors in learning and memory, regulation of aggression, and wakefulness. H 1 receptors are abundantly expressed on neurons and astrocytes. However, to date, studies selectively investigating the roles of neuronal and astrocytic H 1 receptors in behaviour are lacking. We generated novel astrocyte-and neuron-specific conditional knockout (cKO) mice to address this gap in knowledge. cKO mice showed cell-specific reduction of H 1 receptor gene expression. Behavioural assessment revealed significant changes and highlighted the importance of H 1
Histamine is an important monoamine neurotransmitter in the central nervous system (CNS). Histamine is released from histaminergic neurons residing in the tuberomammillary nucleus (TMN) that project throughout the brain. Histamine is involved in many essential physiological processes such as the sleep-wake cycle, anxiety, learning, memory, and stress responses [1] [2] [3] . Alterations in brain histamine levels are closely related to CNS dysfunction and are thought to contribute to various neurological disorders, including Alzheimer's disease and depression 4 . Histamine binds to four distinct G protein-coupled receptors (GPCRs), termed histamine H 1 -H 4 receptors. Previous studies have reported their functional expression in the CNS 5, 6 . Conventional H 1 receptor gene (Hrh1) knockout mice showed significant phenotypical differences compared to controls. For example, exploratory behaviour, aggression, learning, and memory were affected by Hrh1 deletion [7] [8] [9] [10] . Further, pharmacological studies have emphasised the importance of H 1 receptors for wakefulness and cognition in humans 11, 12 .
Although previous studies have provided crucial insights into the role of H 1 receptor signalling in CNS functions, it remains unclear how H 1 receptor-dependent signalling of different cell types contributes to a given phenotype. Hrh1 is abundantly expressed in neurons 5 and astrocytes 13, 14 ; however, until a few decades ago, the functions of astrocytes were poorly understood. Thus, research on the potential contribution of astrocytes to higher brain function was fairly neglected, and findings were traditionally attributed to neuronal signalling. Since then astrocytes have been comprehensively researched and are now accepted as multifunctional cells that critically contribute to CNS physiology 15 . With their end feet closely located at synapses, astrocytes are involved in cerebral blood flow 16 , energy metabolism 17 , ionic homoeostasis 18 , and synaptic function 19, 20 . Growing evidence from rodent studies has stressed the importance of astrocyte signalling in complex behaviours, such as memory and circadian rhythm [21] [22] [23] . Furthermore, various neurological diseases, including Alzheimer's disease and epilepsy, are associated with pathological states of astrocytes in rodents and humans 24, 25 . Recent studies reported a role of H 1 receptor-mediated astrocyte signalling in the regulation of glutamate release and clearance by Supplementary Fig. S1 for full length gels). (C) Body weight was assessed at 12 weeks of age (n = 10-12). Data were analysed with oneway ANOVA and Tukey's post-hoc test. (D) Left: Hrh1 expression in primary astrocyte or neuron cell cultures was assessed with real-time PCR. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) served as an internal control (n = 3-6). Data were analysed with t-test (*p < 0.05 and **p < 0.01). Right: Visualisation of successful recombination at the Hrh1 loxP sites (cropped agarose gel is shown, see Supplementary Fig . S1 for full length gel). NR: no recombination (3244 bp), R: recombination (1106 bp). (E) Left: Hrh1 expression in whole brain homogenates was assessed by real-time PCR. Gapdh served as an internal control (n = 6-7). Data were analysed with one-way ANOVA and Tukey's post-hoc test (*p < 0.05, **p < 0.01 and ***p < 0.001). Right: Visualisation of successful recombination at the Hrh1 loxP sites (cropped agarose gel is shown, see Supplementary Fig . S1 for full length gel). neuronal H 1 receptors are important for recognition memory. It is established that histamine H 1 receptor plays a role in exploratory behaviour, anxiety, and learning, and memory amongst others [7] [8] [9] [10] . A behavioural test battery was set up to investigate potential phenotypic changes in cKO mice. First, cKO mice were subjected to the open-field test to test their exploratory behaviour, but no changes were observed ( Fig. 2A ). The travel time, travel distance, average travel speed, and time spent in the centre of the arena were similar among all groups. Anxiety-like behaviour was assessed in two additional tests: the light-dark box test ( Fig. 2B ) and elevated plus-maze test (Fig. 2C ). During the light-dark box test, both GFAP-Cre Hrh1 f/f and CaMKII-Cre Hrh1 f/f mice spent significantly more time in the illuminated compartment, a measure of reduced anxiety. In the elevated plus-maze test, we did not observe a statistically significant change in anxiety-like behaviour between the groups.
To evaluate memory function in cKO mice, the spontaneous alternation (Y-maze) test and novel object recognition test were performed. The performance of cKO mice in the Y-maze test indicated that spatial learning was not affected by Hrh1 deletion (Fig. 2D ). In contrast, the outcome of the novel object recognition task suggested that recognition memory in mice lacking neuronal H 1 receptors was impaired ( Fig. 2E ). This result is indicated by a significantly reduced preference ratio for CaMKII-Cre Hrh1 f/f mice during the test session compared to that for controls. The deletion of astrocytic H 1 receptors had no impact on recognition memory. In summary, our results showed that exploratory behaviour was not affected by the conditional H 1 receptor deletion. In contrast, anxiety-like behaviour was strongly decreased in both conditional KO mouse models and recognition memory was impaired in mice lacking the neuronal H 1 receptor.
Deletion of astrocytic H 1 receptors increases aggressive behaviour. Previously, a link between H 1
receptors and aggression in conventional Hrh1 KO mice was shown 8 . We studied cKO mice to attribute the regulation of aggressive behaviour to H 1 receptors on either astrocytes or neurons, respectively. Unfamiliar intruders were never attacked by resident Hrh1 f/f controls, but GFAP-Cre Hrh1 f/f residents showed aggressive behaviour in the presence of an unfamiliar intruder ( Fig. 3 ). Within an encounter of 5 minutes, GFAP-Cre Hrh1 f/f mice attacked intruders up to 15 times (Fig. 3A) . On average, the latency of the first attack was 3.5 min, with some mice Table 1 . Concentrations of histamine and 1-methylhistamine in selected brain regions. n = 6. Statistical differences among the groups were determined using one-way ANOVA with Tukey's post-hoc test (*p < 0.05). HA: histamine, 1-MH: 1-methylhistamine.
attacking the intruder for the first time within the first 2 minutes (Fig. 3B ). The average cumulative attack time was 20 s for GFAP-Cre Hrh1 f/f mice (Fig. 3C ). Although a few attacks by CaMKII-Cre Hrh1 f/f mice were observed, the number of attacks was not statistically significant compared to that of control mice. Taken together, data from the resident-intruder test indicated that astrocyte-specific H 1 receptor knockout mice were highly aggressive and suggest a role of H 1 receptors on astrocytes in the regulation of aggressive behaviour.
Deletion of astrocytic H 1 receptors delays the onset of nocturnal activity. The histaminergic sys-
tem is closely associated with wakefulness and sleep and H 1 receptors were shown to affect quantity and quality of wakefulness 12, 31, 32 . Deletion of H 1 receptors could potentially reflect on home cage locomotor activity of Hrh1 cKO mice. Continuous monitoring of mice in their home cages during the light and dark phases revealed that GFAP-Cre Hrh1 f/f mice exhibited obvious changes in locomotor activity when compared to Hrh1 f/f controls ( Fig. 4 ). All groups exhibited very low activity during the light phase. However, while the level of vigilance typically rises quickly after onset of the dark phase and peaks within a few hours, GFAP-Cre Hrh1 f/f mice demonstrated delayed onset of nocturnal activity and were highly active at ZT 18-21 ( Fig. 4A ). In comparison, the www.nature.com/scientificreports www.nature.com/scientificreports/ activity level of controls peaked within the first 3 hours of the dark phase (ZT 12-15). The activity of CaMKII-Cre Hrh1 f/f mice followed the same pattern as that of the control group. Significantly decreased activity of GFAP-Cre Hrh1 f/f mice at ZT 12-15 and increased activity at ZT 18-21 did not impact on their overall activity during the dark phase ( Fig. 4B ).
Taken together, the obtained results showed that astrocytic H 1 receptors are important for high vigilance during the early dark phase.
Qualitative changes in wakefulness in
GfAp-cre Hrh1 f/f mice. Next, we recorded electroencephalograms (EEGs) and electromyograms (EMGs) to investigate whether changes in circadian activity were associated with disturbances in the sleep-wake cycle. The sleep-wake cycle was similar across all groups. cKO and control mice spent the same percentage of time in each stage in all 3 h intervals: wakefulness, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep (Fig. 5A ). The number of bouts and average duration of each stage during light and dark phases were unchanged in cKO mice ( Fig. 5B ,C). Data from EEG power spectra showed the distribution of frequencies during wakefulness, NREM sleep, and REM sleep (Fig. 6 ). The power density of delta waves at 1.5-4 Hz during wakefulness in the day and at night was significantly increased in GFAP-Cre Hrh1 f/f mice (Fig. 6A,B ). Furthermore, we analysed the power density at low frequencies in the range of 0.5-1 Hz during wakefulness, but did not find a significant difference among the groups. Spectral power densities during NREM and REM sleep were similar across all groups (Fig. 6C,D) .
Taken together, these findings indicate that the quantity and quality of sleep were not affected by conditional Hrh1 deletion; however, astrocytic Hrh1 deficiency had a significant impact on the prominence of delta waves at frequencies of 1.5-4 Hz during wakefulness.
Discussion
Histamine H 1 receptors in the CNS are involved in various physiological processes. To date, it remains unknown how neuronal and astrocytic H 1 receptors contribute to different aspects of higher brain function. In this study, we observed that both neuronal and astrocytic H 1 receptors regulated anxiety-like behaviour. Astrocyte-specific Hrh1 knockout mice showed increased aggressive behaviour, altered circadian rhythm, and changes in quality of wakefulness. Finally, neuronal H 1 receptors were important for recognition memory. Astrocyte-specific knockout mice showed increased aggressive behaviour. Aggressive behaviour of male cKO and control mice was assessed using the resident-intruder test. Resident mice were confronted in their home cage with an unfamiliar mouse for 5 min. The number of attacks (A), latency until the first attack (B), and cumulative time of attacks (C) were analysed (n = 11-14). In case of no attack, the latency of first attack was set to 300 s and cumulative time of attacks was set to 0. Statistical significance was assessed with one-way ANOVA and Tukey's post-hoc test (***p < 0.001). In this study, we developed novel cKO mice with selective Hrh1 deletion from either astrocytes or neurons, providing a sophisticated tool to study behaviour in vivo. Hrh1 cKO mice showed significantly decreased Hrh1 expression in astrocytes and neurons. Results from immunohistochemical stainings revealed increased Cre expression in brain sections of CaMKII-Cre mice than in brain sections of GFAP-Cre mice. The increased Cre expression in CaMKII-Cre mice may account for the lower Hrh1 expression in neuron-specific KO mice compared to that in astrocyte-specific KO mice. Moreover, previous research showed that GFAP-Cre transgenic mouse line 77.6 exhibited "scattered mosaic pattern"-like Cre expression 29 . This result may explain why Hrh1 expression was only reduced by half. Future studies will have to investigate whether further reduction of astrocytic Hrh1 expression results in a stronger or distinct phenotype. Hrh1 expression was generally lower in astrocytes than in neurons, suggesting that neuronal H 1 receptors comprise majority of H 1 receptors in the brain. Deletion of H 1 receptors from astrocytes did not affect histamine concentrations in various brain regions of GFAP-Cre Hrh1 f/f mice. In contrast, hypothalamic histamine concentration was twice as high in CaMKII-Cre Hrh1 f/f mice than in controls. Histamine is produced in histaminergic neurons originating in the hypothalamic TMN; it is possible that this may be a compensatory mechanism for impaired H 1 receptor signaling. However, under baseline conditions, histamine release and the concentration of its metabolite 1-methylhistamine are strongly correlated. Therefore, the stable concentration of 1-methylhistamine suggests that histamine release remained unchanged. Dopamine is metabolised to two intermediates, DOPAC and 3-methoxytyramine (3-MT), that are subsequently converted into homovanillic acid (HVA). DOPAC concentrations were increased in two brain regions of CaMKII-Cre mice, but the concentration of 3-MT was not affected. Since the sum of DOPAC, 3-MT, and HVA, which represents the overall metabolism of dopamine, was not altered among the study groups, changes in DOPAC level did not affect the aspects of mouse behaviour that were examined. We assessed behaviour that is reportedly linked to H 1 receptor signalling, including exploratory and anxiety-like behaviour, memory, learning, aggression, and circadian rhythms. Exploratory behaviour of cKO mice was not affected in a novel environment. Although several researchers have reported the involvement of H 1 receptors in exploratory behaviour and found it to be decreased in conventional Hrh1 KO mice 7, 8 , our data did not support these observations. The memory tasks conducted indicated that memory function is complex and involves different cell signaling pathways in the brain. Unlike in a previous study that used conventional Hrh1 mice 33 , the spatial memory function was not affected by conditional Hrh1 deletion. However, CaMKII-Cre Hrh1 f/f mice showed impaired memory function during the novel object recognition test. Mice with astrocytic Hrh1 deficiency did not display any changes. H 1 receptors are known to be important for memory and long-term potentiation in the hippocampus 34, 35 , but the role of H 1 receptors on astrocytes in memory has not been established. To the best of our knowledge, these results show for the first time that neuronal, but not astrocytic, H 1 receptors are important for recognition memory. Further, we observed that anxiety-like behaviour was significantly decreased in both cKO mouse models. In agreement with our findings, an Hrh1 knockout study and a pharmacological study using the H 1 receptor antagonist diphenhydramine reported that H 1 receptor signalling mediated anxiety-like behaviour 8, 36 . Additionally, our results indicated that both neuronal and astrocytic H 1 receptors played a crucial role in anxiety. Our data suggest that both cell types can independently regulate anxiety-like behaviour, but further studies are required to validate the roles of neuronal and astrocytic H 1 receptors in this process.
The debate on how histamine modulates aggression continues to this day 8, [36] [37] [38] . GFAP-Cre Hrh1 f/f mice showed significantly increased aggression towards intruders. The present study reports, for the first time, that H 1 receptors on astrocytes regulate aggressive behaviour. In an earlier study with conventional Hrh1 KO mice, resident mice were significantly less aggressive compared to controls 8 . However, a noticeable difference in the period of individual housing among the previous and the present study, six months versus one weeks, has to be considered when comparing the findings. Other publications by Ray et al. and Nath et al. reported that treatment with H 1 receptor antagonists increased, while H 2 receptor antagonists decreased, foot shock-induced aggressive behaviour 38, 39 . The authors concluded that H 1 and H 2 receptors possess interlinked signalling that can alter aggressive behaviour. The hypothesis regarding the interlinked nature of H 1 and H 2 receptor signalling was further explored by Alonso et al., who revealed active cross-talk and co-trafficking of these two histamine receptors 40 . As astrocytes express both H 1 and H 2 receptors, the question arises whether these receptors have opposing roles and counteract each other in the context of aggression. Our results emphasise the role of H 1 receptors on astrocytes in aggressive behaviour. Nevertheless, further research is required to fully understand the role of astrocytic H 1 receptor signalling and its potential link to H 2 receptor signalling in the context of aggressive behaviour.
Home cage locomotor recordings showed a delayed onset of nocturnal activity in GFAP-Cre Hrh1 f/f mice. The importance of H 1 receptor activation in arousal and wakefulness is well-established 12, 32, 41 , and our data support the concept of astrocytic H 1 receptors as a key player in this process. We conjectured that changes in the level of vigilance may be associated with sleep-wake cycle disturbances; however, EEG/EMG recordings did not indicate any quantitative changes in sleep behaviour, relative time spent in each sleep stage, number of sleep bouts, or average duration of episodes in different sleep stages. Moreover, EEG/EMG recordings revealed that mice were awake after the onset of darkness, similar to controls. These results emphasize that H 1 receptors on astrocytes did not regulate the quantity of sleep, and the observed changes in circadian rhythm were a result of reduced locomotor activity in GFAP-Cre Hrh1 f/f mice. Conventional Hrh1 KO mice showed altered sleep behaviour, with decreased time spent in the wake stage during the early dark phase 32 , but none of the cKO mouse models exhibited this phenotype. There are different scenarios that could explain why the observed phenotype is different from the one previously observed. First, to date, the role of H 1 receptors has been studied with conventional KO mice, which may have had additional impact on the phenotype in previous studies. Conventional KO mice are characterised by non-selective Hrh1 KO in all Hrh1-expressing cells at all times. In contrast, Cre-dependent cKO mice still express the gene of interest until Cre expression ensures cell-specific recombination at the loxP sites and subsequent gene deletion. Therefore, we cannot rule out the possibility that previous observations were associated with these differences between the two mouse models. Second, it is possible that H 1 receptors on astrocytes and neurons jointly regulate sleep behaviour, and conditional gene deletion is insufficient to cause significant changes. It will thus be critical to examine whether double cKO mice, CaMKII-GFAP-Cre Hrh1 f/f , could mimic the phenotype of conventional Hrh1 KO mice. Third, we previously acknowledged the low and "scattered mosaic pattern"-like GFAP-dependent Cre expression. It might be possible that further reduction of Hrh1 expression in astrocytes is required to induce a stronger phenotype, possibly comparable to that of the conventional KO mouse.
To further explore the reasons for reduced vigilance, we investigated the quality of wakefulness and sleep in cKO mice by analysing EEG power spectra of all groups. Although the quality of NREM and REM sleep remained unchanged, astrocyte-specific cKO mice revealed an abnormal increase in delta waves at 1.5-4 Hz during wakefulness. An increase in delta waves during wakefulness has been described by Parmentier et al. in KO mice lacking the histamine-synthesising enzyme histidine decarboxylase 42 . Delta waves are a major indication for insufficient cortical activation and are associated with a drowsy state and low vigilance during wakefulness. Moreover, histamine perfusion significantly decreases the amount of delta waves during wakefulness 43 . We hypothesise that deletion of H 1 receptors from astrocytes prevented activation of signalling cascades, which usually ensure sufficient cortical activity after awakening to maintain high vigilance. H 1 receptor-mediated signalling has the ability to adequately stimulate cortical activity through the activation of cholinergic and serotonergic neurons 2 . It is possible that Hrh1-expressing astrocytes play a critical role in exciting these neurons through the release of bioactive molecules. Concluding from the obtained results, we propose that the histaminergic system is crucial to maintain wakefulness with high vigilance after awakening, and that this signalling is mediated through the activation of H 1 receptors on astrocytes. However, deletion of Hrh1 in astrocytes did not affect the normal sleep-wake cycle, quantity, or quality of sleep, because neither sleep latencies nor the duration of sleep episodes were affected. Wakefulness has typically been associated with H 1 receptors, but previous studies did not confirm distinct roles of neurons and astrocytes in this process. This is the first report indicating that H 1 receptors on astrocytes are important for the maintenance of high vigilance after awakening. Given the incomplete deletion of Hrh1 in astrocytes, it is possible that we are currently observing a phenotype that can somewhat cope with the partial gene deletion resulting in impaired wakefulness, but not disturbed sleep behaviour. It will be of great interest to study spontaneous locomotor activity, sleep, and wakefulness in a mouse model that can achieve complete Hrh1 deletion in astrocytes.
This study provided new functional insights regarding the role of H 1 receptors on neurons and astrocytes, and novel Hrh1 cKO mice were highlighted as a powerful tool to study cell-specific functionality. Nevertheless, several limitations of this study need to be addressed by future research. First, we did not provide data showing the distribution of neuronal and astrocytic H 1 receptors in different brain regions. Currently, there are no good antibodies against the H 1 receptor, and we were unable to design a probe with high sensitivity and specificity for in situ hybridization purposes. Second, this study did not investigate the roles of brain regions implicated in the observed phenotypic changes. Adeno-associated virus (AAV)-mediated delivery of Cre-recombinase can selectively achieve genetic engineering in targeted cell populations and represents an advanced strategy to examine brain circuits involved in H 1 receptor-mediated behaviour in the future. For instance, AAV-mediated regulation of neuronal-specific Cre recombinase expression in the hippocampus will enable investigation of the roles of hippocampal H 1 receptors in memory function. Third, future research should examine the relationship between observed behavioural changes and their underlying molecular mechanisms, as we did not investigate the underpinning cellular changes in cKO mice. It is well established that astrocytes respond to H 1 receptor activation in various ways, including glutamate homeostasis, energy metabolism and inflammatory processes. Thus, it will be important to study molecular changes and their consequences in the cKO mouse, because an interpretation of the observed phenotype can only be speculative at this moment.
Finally, astrocyte-specific KO mouse models that will achieve better Hrh1 deletion have to confirm our observations as current negative results, especially the results that are opposing to those in studies with conventional KO mice, might be a result of incomplete Cre recombination in astrocytes.
In conclusion, our study stresses the importance of H 1 receptors on neurons and astrocytes in distinct physiological processes. Our findings contribute to our understanding of how H 1 receptors on different cell types are involved in the development of pathological states and highlight astrocytes as a novel therapeutic target. www.nature.com/scientificreports www.nature.com/scientificreports/ Methods Animals. Mice were kept on a 12 h light-dark cycle (ZT 0-12: lights on; ZT 12-24: lights off) with controlled humidity and temperature. Unless otherwise described, mice were housed in groups with up to five animals per cage with ad libitum access to a commercial standard diet (Labo MR stock; Nosan Corporation, Yokohama, Japan) and water.
The care and use of animals in this study was conducted in accordance with the Principles for the Care and Use of Research Animals of Tohoku University, Sendai, Japan. All animals and gene-recombination experiments were given ethical approval from the Tohoku University Center for Laboratory Research and Tohoku University Center for Gene Research, respectively.
Generation of cKo mice. Hrh1 f/f mice were designed by UNITECH Co. Ltd (Chiba, Japan). Briefly, a targeting vector was used to introduce two loxP sites into exon 3 of the allele of interest, flanking the coding sequence of Hrh1 (Fig. 1A) . GFAP-Cre (B6.Cg-Tg(Gfap-cre)77.6Mvs/2J) mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and CaMKII-Cre (C57BL/6-TgN(a-CaMKII-nlCre)/10) mice from RIKEN BioResource Center (BRC) (Tsukuba, Japan). Generation of GFAP-Cre Hrh1 f/f and CaMKII-Cre Hrh1 f/f mice, and Cre-recombination, was achieved by crossing Hrh1 f/f mice with GFAP-Cre and CaMKII-Cre mice, respectively. Genotypes of offspring and successful recombination were determined by genomic DNA PCR. Cell-specific deletion of Hrh1 was confirmed with real-time PCR. primary cell cultures. Primary astrocytes and neurons were isolated at P0-P1 as previously described with some modifications 44 . Brains were removed and kept in Hank's balanced salt solution containing 100 IU/ mL benzylpenicillin potassium and 100 μg/mL streptomycin sulphate until the meninges were removed. The tissue was homogenized and incubated with 0.25% trypsin (Nacalai Tesque, Kyoto, Japan) and 0.01% DNase I (Roche Applied Science, Penzberg, Germany) for 10 min at 37 °C. The enzymes were inactivated with horse serum (GE Healthcare Life Sciences, Malborough, MA, USA), following which, the cells were pelleted. Finally, cells for astrocyte cell culture were resuspended in Dulbecco's modified Eagle medium (DMEM)/nutrient mixture F12 (Life Technologies, Carlsbad, CA, USA) supplemented with 10% foetal bovine serum (GE Healthcare Life Sciences), 100 µM non-essential amino acids (Life Technologies), 100 IU/mL benzylpenicillin potassium, and 100 μg/mL streptomycin sulphate. Cells for neuronal cell culture were resuspended in Neurobasal medium (Life Technologies) containing B-27 supplement (Life Technologies) and 0.5 mM l-Alanyl-l-Glutamine (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Resuspended cells were passed through a 100 µm cell strainer (Greiner, Kremsmünster, Austria), and plated on poly-l-lysine (Sigma-Aldrich, St. Louis, MO, USA) coated 6-well plates. The cells were cultured under a humidified atmosphere of 5% (neurons) or 10% (astrocytes) CO 2 at 37 °C. The medium was changed every 3 days until cells were used for further studies.
isolation of genomic DnA. Genomic DNA from mouse tail-cut samples was obtained as described by Truett et al. with minor modifications 45 . The tissue was lysed with 50 mM NaOH at 95 °C for 30 min and subsequent centrifugation. The supernatant was subjected to PCR analysis.
DNA from brain homogenates of mice aged 8-12 weeks old or from primary cell cultures was isolated using the phenol/chloroform method. Cells were lysed and homogenised before chloroform was added. After phase separation, the aqueous phase was used to perform ethanol precipitation and purify the genomic DNA. The dissolved DNA was used for PCR analysis. isolation of total RnA. Total RNA from brain homogenates of mice aged 8-12 weeks was isolated using RNAiso Plus (Takara Bio Inc., Ohtsu, Japan) according to the manufacturer's protocol. Total RNA from primary cell cultures was isolated using NucleoSpin ® RNA Plus (Macherey-Nagel GmbH & Co. KG, Düren, Germany) according to the manufacturer's instructions. conventional pcR. Conventional PCR was run to confirm the presence of the Hrh1 loxP sites, Cre transgene, and successful recombination. Genomic DNA and specific primers ( Table 2) were used with Toyobo KOD FX neo (Toyobo, Osaka, Japan) according to the manufacturer's protocol.
Real-time pcR. Previously isolated RNA from whole mouse brain or primary astrocytes was reverse transcribed with PrimeScript RT Master Mix (Toyobo), according to the manufacturer's protocol. cDNA was run on a two-step PCR using TB Green ™ Premix Ex Taq ™ (Toyobo). The cycling conditions were as follows: pre-denaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 5 s and extension at 60 °C for 30 s. Specific primers for the genes of Hrh1 (5′ → 3′ sense: TCACTCCAGGCCTCACATG; antisense: CAAAGTTCTCATCCCAAGTTTCCA, 95 bp), Cre recombinase (Cre) (5′ → 3′ sense: CGACCAGGTTCGTTC ACTCA; antisense: CAGCGTTTTCGTTCTGCCAA, 186 bp), and glyceraldehyde 3-phosphate dehydrogenase (Gapdh) (5′ → 3′ sense: AGAACATCATCCCTGCATCC; antisense: CACATTGGGGTAGGAACAC, 91 bp) were used for amplification.
Behavioural analysis. Male mice aged 8-12 weeks positively genotyped for one of the three experimental groups were assessed in a series of behavioural tests for exploratory behaviour, anxiety, learning, memory, circadian activity, and aggression. All behavioural experiments were performed during the dark period. During the open field, light-dark box, elevated plus-maze, Y-maze, and locomotor activity tests, the movement tracking software automatically assessed the behaviour of the mice. In the resident-intruder and novel object recognition tests, all novel object recognition. The novel object recognition test was used to assess working memory of cKO mice 48 . The test was carried out in a transparent Plexiglas box (30 × 30 × 30 cm) at 40 lux. The test was performed for 3 days with one session per day. On day 1, mice were habituated and were allowed to freely explore the novel environment without any objects for 10 min. On the next day, mice were familiarised with two identical objects for 5 min. The objects were fixed at two positions with the same distance to the walls. After 24 hours, a test trial was conducted. During the test trial, one of the familiar objects was replaced with an unknown object; mice were allowed to freely explore the environment for 5 min. The objects were made in-house from ordinary laboratory equipment; 75 cm² cell culture flasks filled with water and 50 mL black falcon tubes were used. Both objects were approximately 9 cm high, made from plastic, and featured different colours and shapes. The exploration time reflects the total time spent at both objects together; the cut-off time for total exploration was 20 s. The preference ratio indicates the time spent at the new object relative to the total exploration time. The statistical difference of the preference ratio during training and test session for control mice was confirmed with Student's t-test. Changes in the preference ratio among the experimental groups during the test session were assessed using two-way ANOVA and Bonferroni post-hoc test.
Light-dark box test. The light-dark box test was performed in a box featuring an illuminated (>400 lux)
and a dark (<10 lux) compartment with a small partition, which allowed mice to move between the two compartments 49 . Mice were placed in the dark compartment, and the time spent in each compartment was recorded over 10 min with Opto-Max ® software (Columbus Instrument, Columbus, OH, USA). elevated plus-maze test. The elevated plus-maze test was conducted as previously described with minor modifications 50 . The maze consisted of two open arms and two closed arms with walls on the side and at the end, and a central platform (EPM-04 ® ; Muromachi). The maze was elevated 40 cm from the floor. The light intensity at the central platform was 100 lux. Mice were placed at the end of a closed arm and were allowed to explore the maze for 10 min. SMART ® software (Harvard Apparatus) was used to record movements.
Home cage locomotor activity. Home cage locomotor activity was assessed as previously described 51 .
Mice in individual home cages were habituated for 24 hours prior to the recording of locomotor activity. Locomotor activity was measured by an epoch-making activity monitoring system that uses an infrared beam to sense the animal's movements (SUPERMEX, Muromachi). Data were collected and analysed by the CompACT AMS ® software (Muromachi). The activity counts were summarised in 5 min epochs and recorded continuously for 48 h.
Resident-intruder test.
The resident-intruder test was performed as previously described 52 . Mice (residents) were housed individually for 1 week prior to the experimental day. Testing was performed in the home Measurement of histamine and 1-methylhistamine. Brain regions of interest were isolated from perfused mice and snap frozen in liquid nitrogen. Each brain region was homogenised in 0.4M perchloric acid. Brain homogenates were centrifuged at 15,000 × g for 15 min at 4 °C. Subsequently, the supernatants were transferred to new tubes and centrifuged again as described. The supernatants were transferred before applying the samples to an HPLC system for measurement of histamine and 1-methylhistamine concentrations. Samples were separated on an SC-5ODS column (3.0 mm i.d. × 150 mm; Eicom, Kyoto, Japan) with 0.1 M sodium acetate (pH 4.6)-methanol (91:9, v/v) mobile phase that was supplemented with 220 mg/L sodium 1-octanesulfonate at a flowrate of 500 µL/min at 40 °C. Samples were mixed with 80 mg/L OPA solution containing 2% methanol and 0.004% 2-mercaptoethanol (flowrate: 100 µL/mL), and 0.5 M potassium carbonate solution (flowrate: 100 µL/mL). Histamine and 1-methylhistamine were excited at 335 nm and measured at 450 nm with a fluorescent detector (Hitachi, Tokyo, Japan).
Sleep monitoring. For EEG and EMG recordings, mice were implanted with a head mount (Pinnacle Technology Inc., Laurence, KS, USA) parallel to the sagittal suture. Four stainless steel screws were placed 1.5 mm lateral to the sagittal suture, 2.0 mm anterior of bregma, and 4.0 mm posterior to bregma to record EEG signals. EMG signals were acquired by a pair of multi-stranded stainless steel wires inserted into the neck extensor muscles. One week after surgery, animals were habituated for 3 days before EEG/EMG signals were acquired with a 3-channel EEG/EMG tethered system (Pinnacle Technology Inc.) and digitalised by SIRENIA SLEEP PRO ® software (Pinnacle Technology). EEG and EMG data were recorded in 10 s epochs and automatically scored by Sleep Sign ® software (Kissei Comtec, Matsumoto, Japan). Automatically scored data were manually inspected and corrected if required.
eeG power spectral analysis. EEG spectral power was calculated for 10 s epochs in 0.4 Hz bins using fast Fourier transformation with Sleep Sign ® software (Kissei Comtec). Power spectra were analysed for frequencies 0-25 Hz for each vigilance state in 12-hour intervals (dark and light phases). Data were standardised for each animal by summing up the power of all 0.4 Hz bins across one vigilance state (total power) before determining the percentage of selected frequency ranges. Frequencies selected for analysing were 1.5-4 Hz for delta waves and 6-9 Hz for theta waves. Power spectral densities at different frequency ranges were expressed as percentage relative to the total power. Statistical analysis. All statistical analyses were performed with Prism 5 software (GraphPad, La Jolla, CA, USA). Significant differences were assessed by one-way ANOVA with Tukey's post-hoc test, two-way ANOVA with Bonferroni post-hoc test, or Student's t tests; p < 0.05 was the threshold for statistical significance. Results are expressed as the mean ± standard deviation.
